Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,560
Closed -$1.43M 521
2022
Q2
$1.43M Sell
13,560
-11,732
-46% -$1.5M 0.01% 353
2022
Q1
$4.36M Buy
+25,292
New +$3.78M 0.01% 286
2020
Q1
Sell
-3,500
Closed -$584K 548
2019
Q4
$584K Buy
+3,500
New +$521K ﹤0.01% 378
2015
Q4
Sell
-10,900
Closed -$414K 571
2015
Q3
$414K Buy
+10,900
New +$460K ﹤0.01% 443

Other funds holding AMED

Fred Alger Management's AMED Position: Q3 2022 in Review

Fred Alger Management sold out of Amedisys (AMED) in Q3 2022, closing a stake of 13,560 shares — an estimated $1.43M sold.

Fred Alger Management first reported a position in AMED in Q3 2015 and held it in 4 quarters. The position peaked at $4.36M in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Fred Alger Management reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Fred Alger Management sold 13,560 Amedisys shares in Q3 2022, an estimated $1.43M.
  • Fred Alger Management first reported a position in Amedisys in Q3 2015 and held it in 4 quarters.
  • Fred Alger Management's Amedisys position peaked at $4.36M in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Fred Alger Management's 13F filing for Q3 2022, filed 15 Nov 2022.